Ampio Pharmaceuticals Announces Series D Preferred Stock Dividend to its Holders of Common Stock

Stock Information for Ampio Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Ampio Pharmaceuticals Inc.

Ampio Pharmaceuticals to Present at the Emerging Growth Conference
Ampio Pharmaceuticals Announces Reverse Stock Split
AMPIO PHARMACEUTICALS ISSUES LETTER TO STOCKHOLDERS
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Ampio Pharmaceuticals, Inc.
AMPIO PHARMACEUTICALS ISSUES LETTER TO STOCKHOLDERS
Ampio Pharmaceuticals Regains Compliance with NYSE American Continued Listing Standards
Investors who lost Money with shares of Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) should contact the Shareholders Foundation in connection with the Lawsuit against Ampio Pharmaceuticals, Inc.
Ampio Pharmaceuticals Announces NYSE American Removal of Trading Suspension

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.